102 related articles for article (PubMed ID: 15300201)
1. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.
Weldon CB; Elliott S; Zhu Y; Clayton JL; Curiel TJ; Jaffe BM; Burow ME
Surgery; 2004 Aug; 136(2):346-54. PubMed ID: 15300201
[TBL] [Abstract][Full Text] [Related]
2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
3. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
5. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
6. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
[TBL] [Abstract][Full Text] [Related]
7. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Hussein-Fikret S; Fuller PJ; Gargett CE
J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
[TBL] [Abstract][Full Text] [Related]
8. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
9. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
11. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
13. ErbB receptor signaling and therapeutic resistance to aromatase inhibitors.
Shin I; Miller T; Arteaga CL
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1008s-1012s. PubMed ID: 16467117
[TBL] [Abstract][Full Text] [Related]
14. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.
Le Dily F; Métivier R; Guéguen MM; Le Péron C; Flouriot G; Tas P; Pakdel F
Breast Cancer Res Treat; 2008 Jul; 110(1):69-83. PubMed ID: 17674191
[TBL] [Abstract][Full Text] [Related]
15. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells.
Tai H; Kubota N; Kato S
Biochem Biophys Res Commun; 2000 Jan; 267(1):311-6. PubMed ID: 10623616
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
19. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
20. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
